Maintenance treatment with interferon for advanced ovarian cancer: results of the Northern and Yorkshire gynaecology group randomised phase III study

A randomised phase III trial was conducted to assess the role of interferon-alpha (INFα) 2a as maintenance therapy following surgery and/or chemotherapy in patients with epithelial ovarian carcinoma. Patients were randomised following initial surgery/chemotherapy to interferon-alpha 2a as 4.5 mega-u...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, G D, Brown, J M, Coleman, R E, Stead, M, Metcalf, K S, Peel, K R, Poole, C, Crawford, M, Hancock, B, Selby, P J, Perren, T J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364769/
https://www.ncbi.nlm.nih.gov/pubmed/15305182
http://dx.doi.org/10.1038/sj.bjc.6602037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364769/
https://www.ncbi.nlm.nih.gov/pubmed/15305182
http://dx.doi.org/10.1038/sj.bjc.6602037

Ejemplares similares